Scientific article

IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat

Publication date2009

Recent studies suggest an inflammatory process, characterized by local cytokine/chemokine production and immune cell infiltration, regulates islet dysfunction and insulin resistance in type 2 diabetes. However, the factor initiating this inflammatory response is not known. Here, we characterized tissue inflammation in the type 2 diabetic GK rat with a focus on the pancreatic islet and investigated a role for IL-1. GK rat islets, previously characterized by increased macrophage infiltration, displayed increased expression of several inflammatory markers including IL-1beta. In the periphery, increased expression of IL-1beta was observed primarily in the liver. Specific blockade of IL-1 activity by the IL-1 receptor antagonist (IL-1Ra) reduced the release of inflammatory cytokines/chemokines from GK islets in vitro and from mouse islets exposed to metabolic stress. Islets from mice deficient in IL-1beta or MyD88 challenged with glucose and palmitate in vitro also produced significantly less IL-6 and chemokines. In vivo, treatment of GK rats with IL-1Ra decreased hyperglycemia, reduced the proinsulin/insulin ratio, and improved insulin sensitivity. In addition, islet-derived proinflammatory cytokines/chemokines (IL-1beta, IL-6, TNFalpha, KC, MCP-1, and MIP-1alpha) and islet CD68(+), MHC II(+), and CD53(+) immune cell infiltration were reduced by IL-1Ra treatment. Treated GK rats also exhibited fewer markers of inflammation in the liver. We conclude that elevated islet IL-1beta activity in the GK rat promotes cytokine and chemokine expression, leading to the recruitment of innate immune cells. Rather than being directly cytotoxic, IL-1beta may drive tissue inflammation that impacts on both beta cell functional mass and insulin sensitivity in type 2 diabetes.

  • Animals
  • Antigens, CD/biosynthesis
  • Antigens, Differentiation, Myelomonocytic/biosynthesis
  • Antigens, Differentiation, T-Lymphocyte/biosynthesis
  • Diabetes Mellitus, Experimental/metabolism
  • Diabetes Mellitus, Type 2/metabolism
  • Hyperglycemia/pathology
  • Inflammation/pathology
  • Interleukin 1 Receptor Antagonist Protein/metabolism
  • Interleukin-1/antagonists & inhibitors/metabolism
  • Interleukin-1beta/metabolism
  • Interleukin-6/metabolism
  • Islets of Langerhans/metabolism
  • Macrophages/metabolism
  • Mice
  • Myeloid Differentiation Factor 88/metabolism
  • Rats
  • Rats, Wistar
Citation (ISO format)
EHSES, J A. et al. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. In: Proceedings of the National Academy of Sciences of the United States of America, 2009, vol. 106, n° 33, p. 13998–14003. doi: 10.1073/pnas.0810087106
Main files (1)
Article (Published version)
Secondary files (1)
ISSN of the journal0027-8424

Technical informations

Creation03/30/2010 2:53:00 PM
First validation03/30/2010 2:53:00 PM
Update time03/14/2023 3:26:05 PM
Status update03/14/2023 3:26:04 PM
Last indexation01/15/2024 7:41:07 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack